Cann Pharmaceutical Australia is a joint venture between one of Israel’s largest licensed Medical Grade Cannabis companies, Cann Pharmaceutical Ltd and Australia’s Curus Medical Pty Ltd.
We are a specialty Medical Grade Cannabis group engaged in clinical research, cultivation, processing and extraction & with long standing experience, licensed by governments in Israel and in the Czech Republic. We grow licensed Medical Grade Cannabis (MGC) supplies over two thousand patients each month with stabilised, pharma-grade therapeutic treatments for a range of medical conditions. In addition, we are developing and commercialising innovative therapeutic products.
Our innovative MGC treatments improve the quality of the lives of patients where conventional treatments are not effective.
Cann’s revolutionary, proprietary EP1 epilepsy treatment and unique cannabinoid based whole plant treatment resulted from its two year involvement supplying the Israeli Ministry of Health (MoH) large Refractory Epilepsy Clinical Trial from 2013 involving multiple hospital sites.
The results of this multicentre study with the unique CBD treatment for intractable epilepsy and other forms of drug resistant Epilepsy have been published and are ground breaking. They demonstrated safety end points as well as significant reductions in seizure frequency that is superior over a longer period of time than any other epilepsy trial or product. This provides hope for a large number of Australians with epilepsy.
Australians can apply under the Special Access Scheme of the Therapeutic Goods Administration for the import and/or supply of an unapproved therapeutic good for a single patient, on a case by case basis.
We are in discussions with relevant authorities for cultivation approvals in Australia.
Cann Pharmaceutical Australia is currently partnering with key research institutions in Australia as well as Australian companies in research and clinical trials using better™’s advanced MGC strains. This will entail significant investment from Cann Pharmaceutical Australia and will create job opportunities for Australians.
Approved Medicinal Cannabis Licenses:
- Czech Rep.